Effects of luteinizing hormone-releasing hormone on plasma cocaine levels in rhesus monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 791-799

  Mendelson, Jack H ^a   Mello, Nancy K ^a   Negus, S Stevens ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; GONADORELIN;

ADOLESCENT; AREA UNDER THE CURVE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; HORMONE BINDING; INTRAVENOUS DRUG ADMINISTRATION; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SEX DIFFERENCE;

ANIMALS; AREA UNDER CURVE; COCAINE; FEMALE; GONADOTROPIN-RELEASING HORMONE; HALF-LIFE; INJECTIONS, INTRAVENOUS; LUTEINIZING HORMONE; MACACA MULATTA; MALE; RADIOIMMUNOASSAY; SEX FACTORS;

EID: 0032948950     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (57)

1. Abusada GM, Abukhalaf IK, Alford DD, Vinzon-Bautista I, Pramanik AK, Ansari NA, Manno JE and Manno BR (1993) Solid-phase extraction and GC/MS quantitation of cocaine, ecgonine methyl ester, benzoylecgonine, and cocaethylene from meconium, whole blood, and plasma. J Anal Toxicol 17:353-358.
2. Binienda Z, Bailey JR, Duhart HM, Slikker W Jr and Paule MG (1993) Transplacental pharmacokinetics and maternal/fetal plasma concentrations of cocaine in pregnant macaques near term. Drug Metab Dispos 21:364-368.
3. Carrera MRA, Ashley JA, Parsons LH, Wirsching P, Koob GF and Janda KD (1995) Suppression of psychoactive effects of cocaine by active immunization. Nature (Lond) 378:727-730.
4. Catt KV and Dugau ML (1991) Gonadotropic hormones: Biosynthesis, secretion, receptors and action, in Reproductive Endocrinology, Physiology, Pathophysiology and Clinical Management (Yen SSC and Jaffe RB eds) pp 105-155, W. B. Saunders Co., Philadelphia.
5. Chin WW, Black P, Zervas NT, Ridgway EC and Martin JB (1984) Biosynthesis of the glycoprotein hormones, in Secretory Tumors of the Pituitary Gland (Black P et al. eds) pp 327-342, Raven Press, New York.
6. Crowley WF Jr, Filicori M, Spratt DI and Santoro NF (1985) The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Rec Prog Horm Res 41:473-526.
7. Duhart HM, Fogle CM, Gillam MP, Bailey JR, Slikker W Jr and Paule MG (1993) Pharmacokinetics of cocaine in pregnant and nonpregnant rhesus monkeys. Reprod Toxicol 7:429-437.
8. Evans SM, Cone EJ and Henningfield JE (1996) Arterial and venous cocaine plasma concentrations in humans: Relationship to route of administration, cardiovascular effects and subjective effects. J Pharmacol Exp Ther 279:1345-1356.
9. Ferin M, Carmel PW, Warren MP, Himsworth RL and Frantz AG (1976) Phencyclidine sedation as a technique for handling rhesus monkeys: Effects on LH, GnRH and prolactin secretion. Proc Soc Exp Biol Med 151:428-433.
10. Filicori M, Flamigni C, Dellai P, Cognigni G, Michelacci L, Arnone R, Sambatataro M and Falbo A (1994) Treatment of anovulation with pulsatile gonadotropin-releasing hormone: Prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab 79:1215-1220.
11. Fischman MW, Schuster CR, Javaid J, Hatano Y and Davis J (1985) Acute tolerance development to the cardiovascular and subjective effects of cocaine. J Pharmacol Exp Ther 235:677-682.
12. Fox BS (1997) Development of a therapeutic vaccine for the treatment of cocaine addiction. Drug Alcohol Depend 48:153-158.
13. Fox BS, Kantak KM, Edwards MA, Black KM, Bollinger BK, Botka AJ, French TL, Thompson TL, Schad VC, Greenstein JL, Gefter ML, Exley MA, Swain PA and Briner TJ (1996) Efficacy of a therapeutic cocaine vaccine in rodent models. Nat Med 2:1129-1132.
14. Fuller GB, Hobson WC, Reyes FI, Winter JSD and Faiman C (1984) Influence of restraint and ketamine anesthesia on adrenal steroids, progesterone and gonadotropins in rhesus monkeys. Proc Soc Exp Biol Med 175:487-490.
15. Gorelick DA (1997) Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy. Drug Alcohol Depend 48:159-165.
16. 131I labeled human growth hormone on high specific radioactivity. Biochem J 89:114-123.
17. Jaffe RB (1986) Protein hormones of the placenta, decidua, and fetal membranes, in Reproductive Endocrinology - Physiology, Pathophysiology and Clinical Management (Yen SC and Jaffe RB eds) pp 758-769, 2nd ed., W. B. Saunders Co., Philadelphia.
18. Jaffe RB (1991) The menopause and perimenopausal period, in Reproductive Endocrinology, Physiology, Pathophysiology and Clinical Management (Yen SSC and Jaffe RB eds) pp 389-408, W. B. Saunders Co., Philadelphia.
19. Jatlow PI and Bailey DN (1975) Gas-chromatographic analysis for cocaine in human plasma, with use of a nitrogen detector. Clin Chem 21:1918-1921.
20. Knobil E and Hotchkiss J (1988) The menstrual cycle and its neuroendocrine control, in The Physiology of Reproduction (Knobil E, Neill J, Ewing LL, Greenwald GS, Markert CL and Pfaff DW eds) pp 1971-1994, Raven Press, New York.
21. Kosten TR, Kosten TA, McDougle CJ, Hameedi FA, McCance EF, Rosen MI, Oliveto AH and Price LH (1996) Gender differences in response to intranasal cocaine administration to humans. Biol Psychiatry 39:147-148.
22. Kuhar MJ (1993) Neurotransmitter transporters as drug targets: Recent research with a focus on the dopamine transporter. Pharmacologist 35:28-33.
23. Kuhar MJ, Ritz MC and Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302.
24. Landry DW, Zhao K, Yang G-X, Glickman M and Georgiadis TM (1993) Antibody-catalyzed degradation of cocaine. Science (Washington DC) 259:1899-1901.
25. Leshner AI (1996) Clinical implications of basic research: Molecular mechanisms of cocaine addiction. N Engl J Med 335:128-129.
26. Lukas SE, Mello NK, Drieze JM and Mendelson JH (1995) Buprenorphine-induced alterations of cocaine's reinforcing effects in rhesus monkey: A dose-response analysis. Drug Alcohol Depend 40:87-98.
27. Lukas SE, Sholar M, Lundahl LH, Lamas X, Kouri E, Wines JD, Kragie L and Mendelson JH (1996) Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology 125:346-354.
28. Madras BK, Miller G, Fischman AJ, Bonab A, George S and Meltzer PC (1998) Nonamines: A new view of cocaine recognition sites on monoamine transporters, in Abstracts, College on Problems of Drug Dependence, Sixtieth Annual Scientific Meeting, Scottsdale, AZ, p 86.
29. Matsuzaki M and Misra AL (1977) Comparison of the convulsant effects of cocaine and pseudococaine in the rhesus monkey. Brain Res Bull 2:417-424.
30. Mello NK and Mendelson JH (1997) Cocaine's effects on neuroendocrine systems: Clinical and preclinical studies (special issue on current issues in psychostimulant abuse research). Pharmacol Biochem Behav 57:571-599.
31. Mello NK, Mendelson JH, Drieze J and Kelly M (1990a) Acute effects of cocaine on prolactin and gonadotropins in female rhesus monkey during the follicular phase of the menstrual cycle. J Pharmacol Exp Ther 254:815-823.
32. Mello NK, Mendelson JH, Drieze J and Kelly M (1990b) Cocaine effects on luteinizing hormone-releasing hormone-stimulated anterior pituitary hormones in female rhesus monkey. J Clin Endocrinol Metab 71:1434-1441.
33. Mello NK and Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424.
34. Mello NK, Sarnyai Z, Mendelson JH, Drieze JM and Kelly M (1993) Acute effects of cocaine on anterior pituitary hormones in male and female rhesus monkeys. J Pharmacol Exp Ther 266:804-811.
35. Mello NK, Sarnyai Z, Mendelson JH, Drieze JM and Kelly M (1995) The acute effects of cocaine on anterior pituitary hormones in ovariectomized rhesus monkeys. J Pharmacol Exp Ther 272:1059-1066.
36. Mendelson JH and Mello NK (1996) Drug Therapy: Management of cocaine abuse and dependence. N Engl J Med 334:965-972.
37. Mendelson JH and Mello NK (1998) Cocaine and other commonly abused drugs, in Harrison's Principles of Internal Medicine (Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL and Longo DL eds) pp 2512-2516, McGraw-Hill, Inc., New York.
38. Mendelson JH, Mello NK, Sholar MB, Siegel AJ, Kaufman MJ, Levin JM, Renshaw PF and Cohen BM (1999) Cocaine pharmacokinetics in men and in women during the follicular and luteal phase of the menstrual cycle. Neuropsychopharmacology, in press.
39. Mendelson JH, Sholar M, Mello NK, Teoh SK and Sholar JW (1998) Cocaine tolerance: Behavioral, cardiovascular, and neuroendocrine function in men. Neuropsychopharmacology 18:263-271.
40. Midgley AR (1966) Radioimmunoassay: A method for human chorionic gonadotropin and human luteinizing hormone. Endocrinology 79:10-18.
41. 3H) cocaine in acutely and chronically treated monkeys. Drug Alcohol Depend 2:261-272.
42. National Institute on Drug Abuse (1997) NIDA Epidemiologic Trends in Drug Abuse, National Institute on Drug Abuse, National Institutes of Health, Rockville, MD, NIH Publ. no. 98-4207.
43. Negus SS, Mello NK, Lamas X and Mendelson JH (1996) Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 278:879-890.
44. Negus SS, Mello NK, Portoghese PS, Lukas SE and Mendelson JH (1995) Role of delta opioid receptors in the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 273:1245-1256.
45. Physicians' Desk Reference (1997) 51st ed., Medical Economics Company, Montvale, NJ.
46. Rawson RA, Obert JL, McCann MJ, Castro FG and Ling W (1991) Cocaine abuse treatment: A review of current strategies. J Subst Abuse 3:457-491.
47. Rebar R, Yen SSC, Vandenberg G, Naftolin F, Ehara Y, Engblom S, Ryan KJ, Amoss M and Guillemin R (1973) Gonadotropin responses to synthetic LRF: Dose-response relationship in men. J Clin Endocrinol Metab 36:10-16.
48. Rebar RW (1991) Practical evaluation of hormonal status, in Reproductive Endocrinology (Yen SSC and Jaffe RB eds) pp 830-886, W. B. Saunders Co., Philadelphia.
49. Ritz MC, Lamb RJ, Goldberg SR and Kuhar MJ (1987) Cocaine receptors in dopamine transporters are related to self-administration of cocaine. Science (Washington DC) 237:1219-1223.
50. Sarnyai Z, Mello NK, Mendelson JH, Eros-Sarnyai M and Mercer G (1996) Effects of cocaine on pulsatile activity of the hypothalamic-pituitary-adrenal axis in male rhesus monkeys: Neuroendocrine and behavioral correlates. J Pharmacol Exp Ther 277:225-234.
51. Sholar M, Mendelson JH, Mello NK, Siegel AJ, Kaufman MJ, Levin JM, Renshaw PF and Cohen BM (1998) Concurrent pharmacokinetic analysis of plasma cocaine and adrenocorticotropic hormone in men. J Clin Endocrinol Metab 83:966-968.
52. Toivola PTK, Bridson WE and Robinson JA (1978) Effect of luteinizing hormone-releasing-hormone on the secretion of luteinizing hormone, follicle-stimulating hormone, and testosterone in adult male rhesus monkeys. Endocrinology 102: 1815-1821.
53. Tutton CS and Crayton JW (1993) Current pharmacotherapies for cocaine abuse: A review. J Addict Dis 12:109-127.
54. Veldhuis JD and Johnson ML (1988) In vivo dynamics of luteinizing hormone secretion and clearance in man: Assessment by deconvolution mechanics. J Clin Endocrinol Metab 66:1291-1300.
55. Veldhuis JD, Johnson ML and Dufau ML (1989) Physiological attributes of endogenous bioactive luteinizing hormone secretory bursts in man: Assessment by deconvolution analysis and in vitro bioassay of LH. Am J Physiol 256:E199-E207.
56. Woolverton WL and Johnson KM (1992) Neurobiology of cocaine abuse. Trends Pharmacol Sci 13:193-200.
57. Yen SSC (1991) The human menstrual cycle: Neuroendocrine regulation, in Reproductive Endocrinology (Yen SSC and Jaffe RB eds), 3rd ed., pp 273-308, W. B. Saunders Co., Philadelphia.